SCHEMBL6663678

SCHEMBL6663678

Cc1cc(C=Cc2ccc(N(C)C)cc2)nc(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.51
MEN1 O00255 3/20 0.46
RAB9A P51151 3/20 0.46
KMT2A Q03164 3/20 0.46
NPC1 O15118 2/20 0.46
KLF5 Q13887 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPK1 P28482 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALOX15 P16050 1/20 0.45
CASP1 P29466 1/20 0.45
HBB P68871 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
EGFR P00533 1/20 0.44
RELA Q04206 1/20 0.44
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
APP P05067 7/20 0.43
PTGS1 P23219 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6592035 0.81 KDM4E (0.63) MAPTMEN1RAB9AKMT2ANPC1
SCHEMBL6592031 0.81 KDM4E (0.63) MAPTMEN1RAB9AKMT2ANPC1
SCHEMBL6595104 0.79 KDM4E (0.51) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL6595103 0.79 KDM4E (0.51) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL6668035 0.72 APP (0.66) MAPTMEN1RAB9AKMT2ANPC1
SCHEMBL881864 0.70 APP (0.63) MAPTMEN1RAB9AKMT2ANPC1
SCHEMBL1714446 0.70 RELA (0.81) MAPTMEN1RAB9AKMT2ANPC1
SCHEMBL7915381 0.70 RELA (0.81) MAPTMEN1RAB9AKMT2ANPC1
SCHEMBL13467434 0.70 RELA (0.81) MAPTMEN1RAB9AKMT2ANPC1
SCHEMBL3025040 0.70 RELA (0.81) MAPTMEN1RAB9AKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 WO claimed
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 WO disclosed